NT5DC2 knockdown suppresses progression, glycolysis, and neuropathic pain in triple‐negative breast cancer by blocking the EGFR pathway.
- Resource Type
- Article
- Source
- Molecular Carcinogenesis; Apr2024, Vol. 63 Issue 4, p785-796, 12p
- Subject
- Language
- ISSN
- 08991987